EA200300614A1 - Кристаллические соли металл-глюкозамин сульфата и способы их приготовления - Google Patents
Кристаллические соли металл-глюкозамин сульфата и способы их приготовленияInfo
- Publication number
- EA200300614A1 EA200300614A1 EA200300614A EA200300614A EA200300614A1 EA 200300614 A1 EA200300614 A1 EA 200300614A1 EA 200300614 A EA200300614 A EA 200300614A EA 200300614 A EA200300614 A EA 200300614A EA 200300614 A1 EA200300614 A1 EA 200300614A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- metal
- glucosamine sulfate
- preparation
- new
- relates
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229960002849 glucosamine sulfate Drugs 0.000 abstract 4
- 229910052751 metal Inorganic materials 0.000 abstract 4
- 239000002184 metal Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000005067 joint tissue Anatomy 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Настоящее изобретение относится к новым кристаллическим солям металл-глюкозамин сульфата, которые могут использоваться при лечении как острых, так и хронических форм ревматических и артрических заболеваний и всех патологических состояний, возникающих в результате нарушения обмена веществ в костно-суставных тканях. В частности, настоящее изобретение относится к новым кристаллическим солям металл-глюкозамин сульфата с низким содержанием металла, при этом в качестве металла может применяться либо натрий, либо калий. Настоящее изобретение относится также к приготовлению новых кристаллических солей металл-глюкозамин сульфата с низким содержанием металла и фармацевтических составов, включающих новые кристаллические соли металл-глюкозамин сульфата с низким содержанием металла на основе процесса с использованием раствора и без растворителя.Отчет о международном поиске был опубликован 2003.01.03.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1088MU2000 | 2000-12-01 | ||
| IN1087MU2000 | 2000-12-01 | ||
| IN394MU2001 | 2001-04-26 | ||
| PCT/IN2001/000211 WO2002043653A2 (en) | 2000-12-01 | 2001-12-03 | Crystalline glucosamine sulphate metal salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200300614A1 true EA200300614A1 (ru) | 2004-10-28 |
| EA006632B1 EA006632B1 (ru) | 2006-02-24 |
Family
ID=27272463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200300614A EA006632B1 (ru) | 2000-12-01 | 2001-12-03 | Кристаллические соли металл-глюкозамин сульфата и способы их приготовления |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6812223B2 (ru) |
| EP (1) | EP1347986B1 (ru) |
| JP (1) | JP4307072B2 (ru) |
| KR (1) | KR100842400B1 (ru) |
| CN (1) | CN100351261C (ru) |
| AT (1) | ATE293122T1 (ru) |
| AU (2) | AU2002217416B2 (ru) |
| BG (1) | BG107845A (ru) |
| BR (1) | BR0115801A (ru) |
| CA (1) | CA2436925C (ru) |
| CZ (1) | CZ20031503A3 (ru) |
| DE (1) | DE60110118T2 (ru) |
| DK (1) | DK1347986T3 (ru) |
| DZ (1) | DZ3450A1 (ru) |
| EA (1) | EA006632B1 (ru) |
| ES (1) | ES2240570T3 (ru) |
| HR (1) | HRP20030400A2 (ru) |
| HU (1) | HU229546B1 (ru) |
| IL (2) | IL156100A0 (ru) |
| MA (1) | MA25925A1 (ru) |
| MX (1) | MXPA03004693A (ru) |
| NO (1) | NO324847B1 (ru) |
| NZ (1) | NZ526079A (ru) |
| PL (1) | PL207740B1 (ru) |
| PT (1) | PT1347986E (ru) |
| RO (1) | RO121738B1 (ru) |
| SI (1) | SI21188A (ru) |
| SK (1) | SK285926B6 (ru) |
| WO (1) | WO2002043653A2 (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435812B2 (en) | 2001-12-28 | 2008-10-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Method for preparing a glucosamine compound and compound thus obtained |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7332304B2 (en) | 2002-07-01 | 2008-02-19 | Arkion Life Sciences Llc | Process and materials for production of glucosamine and N-acetylglucosamine |
| US7388000B1 (en) | 2004-09-17 | 2008-06-17 | Jfct Technologies, Llc | Halide-free glucosamine phosphate compositions and methods of preparation |
| US7388001B1 (en) | 2004-09-17 | 2008-06-17 | Jfc Technolries, Llc | Halide-free glucosamine sulfate compositions and methods of preparation |
| US7683042B1 (en) | 2004-09-17 | 2010-03-23 | Jfc Technologies, Llc | Stabilized halide-free glucosamine base and method of preparation |
| US7622576B1 (en) | 2004-09-22 | 2009-11-24 | Jfc Technologies, Llc | Halide-free glucosamine base and method of preparation |
| DE102005033844A1 (de) * | 2005-07-20 | 2007-02-01 | Beiersdorf Ag | Insektenabwehrmittel mit Langzeitwirkung |
| US7854956B2 (en) * | 2007-03-07 | 2010-12-21 | Exportadora De Sal, S.A. De C.V. | Low sodium salt compositions and methods of preparation and uses thereof |
| CN101735283B (zh) * | 2008-11-14 | 2012-07-18 | 徐州海吉亚生物制品有限公司 | 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术 |
| US20110319608A1 (en) * | 2009-11-05 | 2011-12-29 | Mahesh Devdhar | Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride |
| CN106866751B (zh) * | 2017-02-17 | 2019-11-05 | 江苏双林海洋生物药业有限公司 | 一种硫酸氨基葡萄糖复盐的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1148050B (it) * | 1981-04-30 | 1986-11-26 | Rotta Research Lab | Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto |
| DE3532081A1 (de) * | 1985-09-09 | 1987-03-12 | Orion Yhtymae Oy | Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung |
| CH690719A5 (it) * | 1996-08-19 | 2000-12-29 | Rotta Res B V Amsterdam Swiss | Procedimento per la preparazione di sali misti della glucosamina. |
| US5843923A (en) * | 1998-05-22 | 1998-12-01 | Jame Fine Chemicals, Inc. | Glucosamine sulfate potassium chloride and process of preparation thereof |
-
2001
- 2001-12-03 PL PL366386A patent/PL207740B1/pl unknown
- 2001-12-03 AT AT01998306T patent/ATE293122T1/de not_active IP Right Cessation
- 2001-12-03 CZ CZ20031503A patent/CZ20031503A3/cs unknown
- 2001-12-03 DK DK01998306T patent/DK1347986T3/da active
- 2001-12-03 NZ NZ526079A patent/NZ526079A/en not_active IP Right Cessation
- 2001-12-03 HU HU0302154A patent/HU229546B1/hu not_active IP Right Cessation
- 2001-12-03 AU AU2002217416A patent/AU2002217416B2/en not_active Ceased
- 2001-12-03 JP JP2002545632A patent/JP4307072B2/ja not_active Expired - Fee Related
- 2001-12-03 BR BR0115801-5A patent/BR0115801A/pt active Search and Examination
- 2001-12-03 US US10/433,317 patent/US6812223B2/en not_active Expired - Fee Related
- 2001-12-03 DE DE60110118T patent/DE60110118T2/de not_active Expired - Lifetime
- 2001-12-03 PT PT01998306T patent/PT1347986E/pt unknown
- 2001-12-03 CA CA002436925A patent/CA2436925C/en not_active Expired - Fee Related
- 2001-12-03 AU AU1741602A patent/AU1741602A/xx active Pending
- 2001-12-03 SK SK648-2003A patent/SK285926B6/sk not_active IP Right Cessation
- 2001-12-03 WO PCT/IN2001/000211 patent/WO2002043653A2/en active Search and Examination
- 2001-12-03 RO ROA200300464A patent/RO121738B1/ro unknown
- 2001-12-03 EA EA200300614A patent/EA006632B1/ru not_active IP Right Cessation
- 2001-12-03 SI SI200120069A patent/SI21188A/sl not_active IP Right Cessation
- 2001-12-03 KR KR1020037007342A patent/KR100842400B1/ko not_active IP Right Cessation
- 2001-12-03 MX MXPA03004693A patent/MXPA03004693A/es active IP Right Grant
- 2001-12-03 ES ES01998306T patent/ES2240570T3/es not_active Expired - Lifetime
- 2001-12-03 CN CNB018196926A patent/CN100351261C/zh not_active Expired - Fee Related
- 2001-12-03 EP EP01998306A patent/EP1347986B1/en not_active Expired - Lifetime
- 2001-12-03 IL IL15610001A patent/IL156100A0/xx unknown
- 2001-12-03 DZ DZ013450A patent/DZ3450A1/fr active
-
2003
- 2003-05-19 HR HR20030400A patent/HRP20030400A2/hr not_active Application Discontinuation
- 2003-05-23 BG BG107845A patent/BG107845A/bg unknown
- 2003-05-25 IL IL156100A patent/IL156100A/en not_active IP Right Cessation
- 2003-05-30 MA MA27186A patent/MA25925A1/fr unknown
- 2003-06-02 NO NO20032491A patent/NO324847B1/no not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435812B2 (en) | 2001-12-28 | 2008-10-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Method for preparing a glucosamine compound and compound thus obtained |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100184A1 (ru) | Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции | |
| EA200300614A1 (ru) | Кристаллические соли металл-глюкозамин сульфата и способы их приготовления | |
| YU92501A (sh) | Levodop/karbidop/entakapon farmaceutski preparat | |
| NO20053627L (no) | Malonamidderivater som gamma-sekretase inhibitorer | |
| BR0014076A (pt) | Benzamidas e inibidores correlatos do fator xa | |
| BR0209957A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
| RU2007146395A (ru) | Диспергируемые таблетки бозентана | |
| HUP0103851A2 (hu) | VIIa Faktor inhibitorai, eljárás előállításukra, alkalmazásuk és azokat tartalmazó gyógyászati készítmények | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| BR9907025A (pt) | Polissacarìdeos sintéticos, processo para sua preparação e composições farmacêuticas que contêm os mesmos | |
| IT1318535B1 (it) | Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina. | |
| EA200500701A1 (ru) | Новая кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты | |
| BR9912842A (pt) | Processo para a preparação de sal de cálcio de zofenopril | |
| BR9914418A (pt) | Concentrado oral de sertralina | |
| BR0312461A (pt) | Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e métodos para tratamento e profilaxia | |
| DE69509091D1 (de) | Salze von 2-[(2,6-dichlorophenyl)amin]phenylacetoxyessigsäure mit organischen basischen kationen | |
| LT2003051A (en) | Crystalline glucosamine sulphate metal salts and process for preparing the same | |
| EP1325918A4 (en) | CARDIOUS CELL APOPTOSIS INHIBITORS AND TREATMENT / PREVENTION OF HEART DISEASES | |
| MXPA04002868A (es) | Preparacion de solucion acuosa de ecabet sodico. | |
| RU2005111835A (ru) | Способ профилактики и лечения гепатозов у норок | |
| McCarty | Precipitation and deposition of monosodium urate monohydrate crystals in tissues | |
| RU94013445A (ru) | Новое соединение, лейстродуксин н, способ его получения и терапевтическая композиция | |
| GEP20074194B (en) | Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid | |
| BR0314525A (pt) | Composições e métodos para tratamento de disfunção sexual | |
| RU93058599A (ru) | Новые диметиламинооксиалкандифосфоновые кислоты и их соли, способ их получения, содержащие их фармацевтические составы, применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC4A | Change in name of a patent proprietor in a eurasian patent | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |